A patient recently reached out to Doctor Jennifer Walden regarding her breast augmentation and face lift services. Concerned with her decreasing sexual attractiveness due to aging she was eager to discuss her options with Doctor Walden who specializes in cosmetic surgery. The all female staff provided an atmosphere where the patient was able to feel comfortable discussing her concerns as she went through the consultation. Jennifer’s extensive experience in the field of cosmetic surgery showed when every question she asked was answered in full detail. Jennifer was educating the patient on the surgical procedure and what improvements she was to expect after the surgery. “Doctor Walden understood me” said the patient. “Having small breasts feels like a disability when I see my friends flaunting their cleavage to guys”. She wanted to improve her appearance and fix something that bothered her for a long time. “Doctor Walden’s professionalism and absence of judgment allowed me to truly express what I wanted” said the patient. Jennifer Walden provided several breast enhancement options to choose from and she was able to educate the client on her face lift options as well.
Three months after her face lift and breast augmentation procedures the patient expressed an overwhelming feeling of satisfaction and joy. “My life has changed and I feel like a new person, an improved version of what I used to be” she said with a big smile on her face. Procedures that improve a person’s appearance create a new level of self-esteem for Doctor Walden’s patients. Cosmetic surgery allows people to fix things that bother them about themselves. Doctor Jennifer Walden is not just a cosmetic surgeon, she is a healer. Through cosmetic procedures she is able to change people’s lives and bring them to a new level of satisfaction and self-esteem.
In the recent announcement made by Foresite Capital, Molly He has been named its venture partner. Molly He is a Ph.D. holder who formally was a senior director at Illumina. Dr. He has more than 15 years of experience in both genomic and pharmaceutical research. She has earned her fair share of respect in the scientific research. Jim Tananbaum, the managing director of Foresite Capital, was excited to have her on board. He acknowledged Dr. He as a valuable resource for the company especially in its endeavors of expansion. He went ahead to hail her expertise in drug development and leadership skills.
Dr. He is a proud degree holder of biochemistry which she received from Nankai University. She obtained her Ph.D. in protein biophysics from the University of California. Her career began more than 15 years ago. She spent about ten of these years, in the pharmaceutical industry where her focus was mainly on the design of antibody and drugs that target cancer as well as immune diseases. She later headed Pacific Bioscience. From there she joined Illumina where she took charge of the corporation’s global innovation of protein reagent.
Foresite Capital is a firm that supports healthcare leaders by providing them with growth capital. It selects out healthcare leaders that are emerging and those that have product and services that are disruptive in private and public healthcare markets. Jim Tananbaum founded the company. With him is a 25-year entrepreneurial experience in healthcare. He has his eyes focused on strategy, operational and financial opportunities to come up with an authorized healthcare business. Before coming up with Foresite Capital, Jim Tananbaum had co-founded two other biopharmaceutical companies namely GelTex Pharmaceuticals, and Theravance international company. He also co-founded two leading healthcare investments practices.
Jim Tananbaum attended Massachusetts Institute of Technology for his masters of science. He later enrolled in the Harvard Medical School where he attained his Doctor of Medicine (MD). It is from the Harvard Business School where he received his MBA. Jim Tananbaum has served on the advisory board at the Yale Presidential Advisory Council. Besides that, Jim Tananbaum is active on the social media platforms. More details can be found on Bloomberg.